Will Novavax Stock Ever Reach Its All-Time High Again?

Novavax (NASDAQ: NVAX) investors are no strangers to tragedy. On Feb. 9 in 2021, shares of the coronavirus vaccine developer hit their all-time high of $331.68. Now, the stock trades at around $50.

But for the first time, the biotech is both profitable and growing. Are longtime shareholders doomed to heavy losses forever, or will Novavax return to its glory days?

Image source: Getty Images.

Continue reading

Source Fool.com